Target intelligence / Profile preview

Andes virus envelope glycoprotein Gn (Gn)

Target
Gn
Molecular classification
Viral envelope glycoprotein, Structural protein, Class II fusion machinery component (as part of Gc/Gn spike complex), Surface antigen
01

Overview

Andes virus envelope glycoprotein Gn is a structural glycoprotein present on the surface of Andes virus, a highly pathogenic member of the Hantavirus genus (family Hantaviridae). Gn, together with the Gc glycoprotein, forms heterodimeric and tetrameric spike complexes that constitute the virus's outer envelope lattice. The Gn glycoprotein is essential for viral assembly, cell entry (including receptor binding and trafficking), and budding. Its cytoplasmic tail mediates critical interactions with ribonucleoprotein particles necessary for viral replication and assembly[1][2][4][7][8]. Structurally, Gn is a type I transmembrane protein with a large ectodomain and a cytoplasmic tail that includes a zinc finger domain implicated in protein–protein binding[1][2]. Gn is immunogenic, representing a principal target for virus-neutralizing antibodies and a candidate for vaccine development[4][5][7]. Andes virus and its glycoproteins are the central agents in hantavirus cardiopulmonary syndrome (HCPS) in South America, for which there are no approved therapeutics; current medical research aims to exploit Gn as a therapeutic and diagnostic target[4][7][8].

Other names
GnHantavirus envelope glycoprotein GnEnvelope protein N (Gn)
02

Mechanism of action

Inhibiting virus–cell entry (by blocking Gn/host receptor or interfering with spike function; mainly theoretical or vaccine/antibody-based) Inhibiting glycoprotein-mediated fusion

03

Biological functions

Virus assemblyVirus entry (mediates cell attachment and entry)Virus buddingProtein–protein interaction (with nucleocapsid protein)Antigenicity, target of neutralizing antibody response
04

Disease associations

Infection (critical for Andes virus infectivity, transmission, and pathogenesis)Zoonotic transmission (instrumental in Andes virus outbreaks in humans)Human disease association: Hantavirus cardiopulmonary syndrome (HCPS)
05

Safety considerations

No approved drugs—vaccine development targeting Gn must avoid antibody-dependent enhancement or off-target immune effectsRapid viral mutation as a challenge to vaccine/antibody efficacy
06

Interacting drugs

None approved; neutralizing antibodies experimentally described

1 more in the full profile.

07

Biomarkers

Presence of anti-Gn antibodies as marker of immune response and prior infectionGn antigen as marker of infection in diagnostics (experimental)

Beyond the preview

Go deeper on Andes virus envelope glycoprotein Gn (Gn).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Andes virus envelope glycoprotein Gn (Gn).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call